EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity

Emily Ross-Munro, Esra Isikgel, Bobbi Fleiss iD

Biomolecules · 11.11.2024 · 14 (11) · 1434

DOI: 10.3390/biom14111434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 11.11.2024. Verfasst von Emily Ross-Munro und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Health & Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia. Hauptthemen laut MEDLINE: Plant Extracts, Cannabis, Dronabinol, Microglia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fenix Innovations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence has accumulated that Cannabis-derived compounds have the potential to treat neuroinflammatory changes present in neurodevelopmental conditions such as autism spectrum disorder. However, research is needed on the specific brain health benefits of strains of whole Cannabis extract that are ready for commercial production. Here, we explore the anti-inflammatory and neuroprotective effects of NTI-164, a genetically unique high-cannabidiol (CBD), low-Δ9-tetrahydrocannabinol extract, and also CBD alone on BV-2 microglia and SHSY-5Y neurons. Inflammation-induced up-regulation of microglial inflammatory markers was significantly attenuated by NTI-164, but not by CBD. NTI-164 promoted undifferentiated neuron proliferation and differentiated neuron survival under excitotoxic conditions. These effects suggest the potential for NTI-164 as a treatment for neuropathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsCannabisDronabinolMicrogliaInflammationAnimalsHumansMiceNeuronsNeuroprotective AgentsCannabidiolAnti-Inflammatory AgentsCell LineCell ProliferationCell Survival

Stichwörter der Autor:innen

autismbotanical synergyfull spectrumneurodevelopmental disordersneuroinflammation

Substanzen

Plant ExtractsDronabinolNeuroprotective AgentsCannabidiolAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Health & Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia.
  • Fenix Innovation Group Pty Ltd., Melbourne, VIC 3149, Australia.

ORCID-Profile: Bobbi Fleiss

Förderung

  • Fenix Innovations

Zitieren

APA

Ross-Munro, E., Isikgel, E., & Fleiss, B. (2024). Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity. Biomolecules, 14(11), 1434. https://doi.org/10.3390/biom14111434

Vancouver

Ross-Munro E, Isikgel E, Fleiss B. Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity. Biomolecules. 2024;14(11):1434. doi:10.3390/biom14111434

BibTeX
@article{RossMunro2024,
  author = {Ross-Munro, Emily and Isikgel, Esra and Fleiss, Bobbi},
  title = {Evaluation of the Efficacy of a Full-Spectrum Low-THC Cannabis Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {1434},
  doi = {10.3390/biom14111434}
}
Kostenlos starten →